Univest
Univest
  • Markets

Acutaas Chemicals Q4 FY26 Results Preview

  • March 12, 2026
  • Posted by: Neeraj Pandey
  • Category: News
No Comments
Acutaas Chemicals Q4 FY26 Results Expectations

Acutaas Chemicals Q4 FY26 results date is all set to be announced soon and most investors are awaiting it. Professionals are expecting an increase in revenue due to higher sales and a significant rise in PAT. Acutaas Chemicals was listed on the National Stock Exchange (NSE) on 14-Sep-2021. Acutaas Chemicals share has its face value of 5 per share, and its NSE symbol is ACUTAAS. The company operates in the Materials sector and primarily belongs to the Specialty Chemicals industry.

Table of Contents

Toggle
  • Acutaas Chemicals Q4 Results 2026 Preview
  • Acutaas Chemicals Share Performance
  • Key Factors to Watch for Acutaas Chemicals Q4 Results FY26
  • About Acutaas Chemicals
  • Final Thoughts
  • Recent Articles

Acutaas Chemicals Q4 Results 2026 Preview

  • Acutaas Chemicals Q4 FY26 revenue is expected to be around Strong Growth Expected, representing a 18-24% YoY increase compared to the same quarter last year.
  • Profit After Tax, or PAT, is projected to rise 20-27% YoY.
  • EBITDA to rise 19-25%.
  • Acutaas Chemicals is expected to show Strong Growth Expected in its revenue. 

Click and Sign Up to Get Live Updates on Q4 Results

Acutaas Chemicals Share Performance

  • Over the past six months, Acutaas Chemicals share price has Up by 33% to 2,153.90.
  • Moreover, over the past year, the stock has Up by 58%
  • Despite this weak short-term performance, Acutaas Chemicals stock has delivered a financially sound 300% return over the past 5 years.
  • As of today, 12-03-2026, the Acutaas Chemicals share price is trading at 2,153.90 per share.

Key Factors to Watch for Acutaas Chemicals Q4 Results FY26

  • Revenue Growth & Segment Performance – Focus on topline growth in the Specialty Chemicals industry within the Materials sector.
  • Occupancy Levels & Seat Expansion – Monitor operational expansion and capacity utilisation trends.
  • Profitability & Margin Trends – Track EBITDA and PAT margins to evaluate cost control and operating efficiency.
  • Order Book & New Client Wins – Watch for updates on new contracts, partnerships, and long-term deals.
  • Balance Sheet & Cash Flow Position – Review debt levels, working capital management, and operating cash flows for financial stability.

About Acutaas Chemicals

Acutaas Chemicals is engaged in manufacturing and supplying specialty chemical intermediates and value-added products, catering to sectors like pharmaceuticals, agrochemicals, and industrial applications, with a focus on serving both domestic and international markets through a diversified product portfolio.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Final Thoughts

Acutaas Chemicals is gear up to announce its Q4 FY26 results. Analysts expect 18-24% revenue growth, a 20-27% rise in PAT, and a 19-25% rise in EBITDA. Acutaas Chemicals focuses on revenue growth from order execution, margin improvement, a strong order book, and management.

Stay informed with Univest blogs to get real-time updates on Acutaas Chemicals Q4 results FY26. 

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Recent Articles

Allied Blenders Q4 FY26 Results: Sales Growth Expectations

Alkem Laboratories Q4 FY26 Results: Earnings Expectations

Akzo Nobel India Q4 FY26 Results: Revenue and Profit Outlook

Aditya Birla Lifestyle Brands Q4 FY26 Results: Revenue Outlook

Aditya Birla Capital Q4 FY26 Results: Revenue and Earnings Outlook



News Q4 results expectations
Author: Neeraj Pandey
Neeraj Pandey is a Financial Content Writer at Univest, covering Indian equity markets with a specialisation in quarterly earnings previews and analyst consensus analysis. His published work tracks Q4 FY26 results across 10+ sectors — from IT heavyweights like Infosys and TCS to PSUs like Coal India and Balmer Lawrie, and mid-caps like Neuland Laboratories, MCX, and Whirlpool of India. His writing approach is data-first: every article anchors on NSE/BSE filings, analyst consensus estimates (revenue, PAT, EBITDA margins), 52-week price context, and YoY/QoQ comparisons — giving retail investors the same structured framework institutional desks use before an earnings event. He combines SEO-optimised structure with rigorous data sourcing, ensuring each preview ranks for investor search intent while meeting SEBI editorial standards. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards.

Leave a Reply Cancel reply